|
July. 25, 2006 |
|
|
Dec. 17, 2018 |
|
|
jRCT2080220281 |
A randomized-controlled, double-blinded, phase III study of CS-866AZ |
|
| version: date: |
DAIICHI SANKYO COMPANY, LIMITED |
||
http://www.daiichisankyo.co.jp/contact/index.html |
||
Interventional |
||
Double blind comparative study |
||
3 |
||
Mild to moderate essential hypertension with aged 20 years or older |
||
| 20age old over | ||
| No limit | ||
Both |
||
Essential hypertension |
||
investigational material(s) |
||
Efficacy and safety |
||
| DAIICHISANKYO Co.,Ltd. | |
| JapicCTI-060286 | |